Cargando…
Mitophagy in Parkinson’s Disease: Pathogenic and Therapeutic Implications
Neurons affected in Parkinson’s disease (PD) experience mitochondrial dysfunction and bioenergetic deficits that occur early and promote the disease-related α-synucleinopathy. Emerging findings suggest that the autophagy-lysosome pathway, which removes damaged mitochondria (mitophagy), is also compr...
Autores principales: | Gao, Fei, Yang, Jia, Wang, Dongdong, Li, Chao, Fu, Yi, Wang, Huaishan, He, Wei, Zhang, Jianmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632845/ https://www.ncbi.nlm.nih.gov/pubmed/29046661 http://dx.doi.org/10.3389/fneur.2017.00527 |
Ejemplares similares
-
Tau Pathology in Parkinson's Disease
por: Zhang, Xue, et al.
Publicado: (2018) -
Exploring therapeutic potential of mitophagy modulators using Drosophila models of Parkinson’s disease
por: Asthana, Jyotsna, et al.
Publicado: (2022) -
ATPase Thorase Deficiency Causes α-Synucleinopathy and Parkinson’s Disease-like Behavior
por: Gao, Fei, et al.
Publicado: (2022) -
Therapeutic targeting of mitophagy in Parkinson's disease
por: Masaldan, Shashank, et al.
Publicado: (2022) -
Liquid-liquid phase separation regulates alpha-synuclein aggregate and mitophagy in Parkinson’s disease
por: Hou, Kaiying, et al.
Publicado: (2023)